<DOC>
	<DOCNO>NCT01699347</DOCNO>
	<brief_summary>Cohort study evaluate efficacy treatment OK-432 cystic malformation head neck region . The malformation macrocystic preevaluation include CT/MRI , US blood test . The injection OR US guide , maximal dose 0.2mg . The follow-up short term - till 30 day post injection long term - follow-up wil till 2 year .</brief_summary>
	<brief_title>Cohort Prospective Study Children With Head Neck Cystic Malformation Who Are Treated With Intracystic OK432</brief_title>
	<detailed_description>A cohort study , injection patient study go : 1 . CT/MRI 2 . US estimate cyst size 3 . CBC , PT , PTT , INR , ASLO 4 . ECG If patient qualify study parent sign inform consent , child photograph AP lateral . The injection hold OR US guidance 18q20 gauge needle , first cyst content suck OK432 inject . After injection child stay one night general anesthesia 4 hour case local anesthesia . Short term follow - 3-5 day phone , : till 30 day injection US , still photo . Long term follow-up : 6 month , 1 year , 2 year</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Picibanil</mesh_term>
	<criteria>LYMPHATIC MALFORMATION MACROCYSTIC OR MIXED WITH MORE THEN 50 % MACROCYSTIC . ONLY IN THE HEAD AND NECK AREA TIME FROM OPERATION AT LEAST 6 MONTHS penicillin allergy pregnancy familial history RF Post streptococcal glomerulonephritis Background illnessheart , kidney , lung fever &gt; 38.5c op day URT Infection Family history PANDAS</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>OK432 , CYSTIC MALFORMATION</keyword>
</DOC>